These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25184494)

  • 1. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
    Candelaria NR; Addanki S; Zheng J; Nguyen-Vu T; Karaboga H; Dey P; Gabbi C; Vedin LL; Liu K; Wu W; Jonsson PK; Lin JZ; Su F; Bollu LR; Hodges SE; McElhany AL; Issazadeh MA; Fisher WE; Ittmann MM; Steffensen KR; Gustafsson JÅ; Lin CY
    PLoS One; 2014; 9(9):e106289. PubMed ID: 25184494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
    Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
    J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
    Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
    J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
    Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
    Guillaumond F; Bidaut G; Ouaissi M; Servais S; Gouirand V; Olivares O; Lac S; Borge L; Roques J; Gayet O; Pinault M; Guimaraes C; Nigri J; Loncle C; Lavaut MN; Garcia S; Tailleux A; Staels B; Calvo E; Tomasini R; Iovanna JL; Vasseur S
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2473-8. PubMed ID: 25675507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
    Chun SG; Zhou W; Yee NS
    Cancer Biol Ther; 2009 Jul; 8(14):1328-39. PubMed ID: 19421011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development.
    Pinto CL; Kalasekar SM; McCollum CW; Riu A; Jonsson P; Lopez J; Swindell EC; Bouhlatouf A; Balaguer P; Bondesson M; Gustafsson JÅ
    Mol Cell Endocrinol; 2016 Jan; 419():29-43. PubMed ID: 26427652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
    Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma.
    Wang X; Xie J; Lu X; Li H; Wen C; Huo Z; Xie J; Shi M; Tang X; Chen H; Peng C; Fang Y; Deng X; Shen B
    Cancer Lett; 2017 Jul; 399():1-9. PubMed ID: 28428074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.
    Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Delgado JR; Perales S
    Pancreas; 2016 Feb; 45(2):269-80. PubMed ID: 26495790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.
    Fan A; Wang Q; Yuan Y; Cheng J; Chen L; Guo X; Li Q; Chen B; Huang X; Huang Q
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C216-26. PubMed ID: 26669941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inhibition Mechanism of Pancreatic Ductal Adenocarcinoma via LXR Receptors: A Multifaceted Approach Integrating Molecular Docking, Molecular Dynamics and Post-MD Inter-Molecular Contact Analysis.
    Agar S; Akkurt B; Ulukaya E
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4103-4109. PubMed ID: 38156844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway.
    Fu W; Yao J; Huang Y; Li Q; Li W; Chen Z; He F; Zhou Z; Yan J
    Cell Physiol Biochem; 2014; 33(1):195-204. PubMed ID: 24481266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.